Zhongda Hospital

This study tests whether adding a common heart medication (propranolol) to standard hormone therapy before prostate removal can improve outcomes for men with high-risk prostate cancer. About 30 participants will receive the combination treatment for several months before surgery.…

This study tests whether adding two extra drugs to standard hormone therapy can more thoroughly clear high-risk prostate cancer before surgery. About 94 men will receive the combination, then have their prostate removed to check for remaining cancer cells. The goal is to see if t…

This study tests whether adding a nerve-blocking procedure (endovascular denervation) to standard treatments (TACE/HAIC and immune-targeted therapy) can help people with advanced liver cancer that has spread to the portal vein. The cancer must have gotten worse after initial trea…

This study tests a new type of endoscopic surgery for stomach tumors that grow outward from the stomach wall. The goal is to see if the procedure is safe and can completely remove the tumor. About 20 adults whose CT scans show these outward-growing tumors will take part. The stud…

This study will look at 5000 adults having non-cardiac surgery to see if changes in blood pressure during anesthesia and the operation are linked to kidney injury after surgery. The goal is to better understand how to prevent kidney problems. Participants are not given any new tr…

This study will review the medical records of 200 adults with heart failure, moderate-to-severe chronic kidney disease, and anemia who took roxadustat for at least a year. Researchers want to see if the drug improved heart function and reduced serious heart events. This is an obs…